Neoplasia/BPH

	Exosomal microRNAs as prostate cancer biomarkers and treatments: recent progress. Med Oncol Mahjoubin-Tehran M, Rezaei S. PMID: 41284143 [PubMed - in process]
	Impact of sodium glucose cotransporter 2 inhibitors on bladder cancer and breast cancer: a pharmacovigilance analysis and mendelian randomization study. Expert Opin Drug Saf Xu B, Zhang T, He Y, Jiang A, Liu Y, He Z, Zhou J. PMID: 41283794 [PubMed - as supplied by publisher]
	Improving Quality of Life Through Supervised Exercise in Oncology: A Systematic Review and Meta-Analysis of Randomized Trials in Breast and Prostate Cancer. J Funct Morphol Kinesiol Cano-Uceda A, De Sousa-De Sousa L, Bueno-Fermoso R, Rozalén-Bustín M, Lucio-Allende C, Barba-Ruiz M, Sánchez-Barroso L, Maté-Muñoz JL, García-Fernández P. PMID: 41283560 [PubMed - in process]
	Complete Blood Count-Derived Inflammatory Markers and C-Reactive Protein in Testicular Cancer: Diagnostic and Prognostic Utility. Med Sci (Basel) Puia D, Iv, Cauni VM, Corlade-Andrei M, Pricop C. PMID: 41283275 [PubMed - in process]
	Automated Detection and Grading of Renal Cell Carcinoma in Histopathological Images via Efficient Attention Transformer Network. Med Sci (Basel) Al-Kuwari H, Alshami B, Al-Khinji A, Haider A, Arsalan M. PMID: 41283258 [PubMed - in process]
	Role of Stereotactic Ablative Radiotherapy in Primary Renal Cell Carcinoma: A Review of Clinical Trials. Indian J Surg Oncol Sarma G, Bora H, Medhi PP. PMID: 41283134 [PubMed - in process]
	Clinicopathological Profiles and Outcomes of Low vs High PSA Metastatic Prostate Adenocarcinoma: a Retrospective Study from a Single Tertiary Care Centre in South India. Indian J Surg Oncol Kumar U, Farooq M, Shivashangari MM, Nagasubramanian S, Jeyaseelan L, George AJP, John NT, Kumar S. PMID: 41283117 [PubMed - in process]
	Role of Portal Vein Embolization Alone in Surgical Management of Locally Advanced Gall Bladder Cancer (PROVE-GBC): A Prospective Clinical Trial. Indian J Surg Oncol Dash NR, Mohapatra V, Madhusudan KS, Pal S, Agarwal L. PMID: 41283093 [PubMed - in process]
	Identification and Validation of Cuproptosis-Related Signature to Predict Prognosis and Characterize Tumor Immune Infiltration in Kidney Clear Cell Carcinoma. Indian J Surg Oncol Ding Y, Zhao L, Zhang L, Zhang X, Gu T, Zhang Y, Bu L, Zhang S, Luo J. PMID: 41283082 [PubMed - in process]
	Progress in targeted therapy for prostate cancer via cell surface proteins (Review). Biomed Rep Luo H. PMID: 41282505 [PubMed - in process]
	ST8SIA6-AS1 serves as a prognostic biomarker in cancer and exhibits oncogenic properties in prostate cancer. Front Genet Wen Y, Yang J, Zhan S, Huang Y, Chen G, Zheng S, Zhu S. PMID: 41282486 [PubMed - in process]
	Recent progress on tyrosine kinase inhibitors resistance in renal cell carcinoma: another brick in the wall? Cancer Drug Resist Dong Z, Li S, Li M, Fan M, Chen K, Li A, Wang K, Zhang X. PMID: 41281942 [PubMed - in process]
	Integrated Analysis of Single-Cell RNA Sequencing and Machine Learning Reveals a T Cell-Specific PANoptosis Signature Predicting Prognosis and Immunotherapy in Prostate Cancer. Hum Mutat Wang H, Li W, Deng W, Wu J, Li K, Huang X. PMID: 41281377 [PubMed - in process]
	Biodistribution and Semiquantitative Analysis of (99m)Tc-HYNIC-PSMA-11in Prostate Cancer Patients: A Retrospective Study. Indian J Nucl Med Tayal S, Sinha R, Shukla V, Venkatachalam MM, Suresh A, Kumar JP, Chauhan MR, Jain Y, Jha UN, Kalra S. PMID: 41281176 [PubMed - in process]
	Lower Serum Chloride at ICU Admission Is Associated With Acute Kidney Injury in Critically Ill Solid Tumour Patients: A Retrospective Cohort Study. Cureus Wang C, Li L, Liu D, Liu Y. PMID: 41281063 [PubMed - in process]
	Performance of PRIMARY Score based on PSMA-PET imaging in suspected prostate cancer patients with different PSA ranges: a retrospective study. Am J Nucl Med Mol Imaging Zhang F, Li X, Zhang J, Quan Z, Zhang Z, Han T, Meng X, Ma L, Yu X, Qin W, Kang F. PMID: 41280559 [PubMed]
	Genetic Testing and Counselling for Hereditary Renal Carcinoma: What Do Clinicians Need to Know? Eur Urol Open Sci Re C, Pecoraro A, Stewart GD, Caliò A, Erdem S, Kalayci T, Uyguner ZO, Larcher A, Campi R, Amparore D, Whitworth J, Marandino L, European Association of Urology Young Academic Urologists Renal Cancer Working Group. PMID: 41280159 [PubMed - in process]
	Refining Active Surveillance Eligibility in Intermediate-risk Non-muscle-invasive Bladder Cancer: The Impact of Time to First Recurrence. Eur Urol Open Sci Finati M, Schiavone N, Barone B, Contieri R, Fanelli A, Cinelli F, Ricapito A, d'Altilia N, Falagario UG, Naspro R, Pandolfo SD, Crocetto F, Imbimbo C, Bettocchi C, Cormio L, Carrieri G, Pradere B, Busetto GM. PMID: 41280158 [PubMed - in process]
	Can Prostate Cancer Screening Reduce Mortality in Men Aged 75-79 Years? A Protocol for Target-trial Emulation. Eur Urol Open Sci Abbadi A, Micoli C, Discacciati A, Olarte Parra C, Lantz A, Björnebo L, Arvendell M, Chandra Engel J, Andersson J, Falagario U, Grönberg H, Eklund M, Clements M, Nordström T. PMID: 41280154 [PubMed]
	A retrospective study of the incidence of cancer and associated risk factors in kidney transplant patients in a Latin American population between 2007 and 2022. SAGE Open Med Torres R, Montero Cetina JC, Mendoza E, Reina M, Ruano C, Andrade Fonseca D, Rosselli San Martin C, Flechas Lopez JA, Olivares O. PMID: 41278523 [PubMed]

Articles 1 - 20 / 268682

Page 1 of 13435



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy